How To Use CPT Code 0490T

CPT 0490T describes the autologous adipose-derived regenerative cell therapy for scleroderma in the hands, specifically for multiple injections in one or both hands. This article will cover the description, procedure, qualifying circumstances, appropriate usage, documentation requirements, billing guidelines, historical information, and examples.

1. What is CPT Code 0490T?

CPT 0490T can be used to report the autologous adipose-derived regenerative cell therapy for scleroderma in the hands. This code is specifically used for multiple injections in one or both hands. It should not be reported for a single injection.

2. Official Description

The official description of CPT code 0490T is: ‘Autologous adipose-derived regenerative cell therapy for scleroderma in the hands; multiple injections in one or both hands.’

3. Procedure

1. The provider begins by harvesting the patient’s own fat cells through liposuction.
2. The harvested fat cells undergo various processes to achieve a specific concentration and dilution of regenerative cells.
3. The provider then administers multiple injections of the regenerative cells into one or both hands of the patient.
4. This procedure is performed on the same day as the liposuction and is aimed at treating scleroderma, an autoimmune disease that affects the connective tissue and causes skin tightness.

4. Qualifying circumstances

CPT 0490T is appropriate for patients with scleroderma in the hands who require multiple injections of autologous adipose-derived regenerative cell therapy. It should not be reported in conjunction with codes 15769, 15771, 15772, 15773, 15774, 15876, 15877, 15878, 15879, 20600, or 20604. Additionally, it should not be reported for a single injection, as that would require the use of code 0489T.

5. When to use CPT code 0490T

CPT code 0490T should be used when a patient with scleroderma in the hands undergoes multiple injections of autologous adipose-derived regenerative cell therapy. It should not be used for a single injection or in conjunction with the specified codes mentioned earlier.

6. Documentation requirements

To support a claim for CPT code 0490T, the provider must document the following:

• The patient’s diagnosis of scleroderma in the hands
• The need for multiple injections of autologous adipose-derived regenerative cell therapy
• The date of the procedure
• The specific concentration and dilution of regenerative cells used
• The number of injections administered in each hand
• The signature of the provider performing the procedure

7. Billing guidelines

When billing for CPT code 0490T, ensure that the procedure involves multiple injections in one or both hands for the treatment of scleroderma. It should not be reported with the specified codes and should not be used for a single injection. Additional tips for reporting this code may be obtained from the relevant coding guidelines and resources.

8. Historical information

CPT code 0490T was added to the Current Procedural Terminology system on January 1, 2018. There have been no updates or changes to the code since its addition.

9. Examples

1. A patient with scleroderma in both hands undergoes multiple injections of autologous adipose-derived regenerative cell therapy to improve skin tightness and manage the condition.
2. A provider administers multiple injections of regenerative cells in one hand of a patient with scleroderma to address skin tightness and improve hand function.
3. Multiple injections of autologous adipose-derived regenerative cell therapy are performed in both hands of a patient with scleroderma to alleviate symptoms and enhance quality of life.
4. A provider administers multiple injections of regenerative cells in one hand of a patient with scleroderma to improve skin flexibility and reduce discomfort.
5. Both hands of a patient with scleroderma receive multiple injections of autologous adipose-derived regenerative cell therapy to target skin tightness and promote better hand mobility.
6. A provider performs multiple injections of regenerative cells in one hand of a patient with scleroderma to alleviate symptoms and enhance hand function.
7. Multiple injections of autologous adipose-derived regenerative cell therapy are administered in both hands of a patient with scleroderma to improve skin elasticity and reduce pain.
8. A provider administers multiple injections of regenerative cells in one hand of a patient with scleroderma to address skin tightness and improve hand dexterity.
9. Both hands of a patient with scleroderma undergo multiple injections of autologous adipose-derived regenerative cell therapy to manage symptoms and improve overall hand function.
10. A provider performs multiple injections of regenerative cells in one hand of a patient with scleroderma to alleviate skin tightness and enhance hand flexibility.